-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Upgrades NeoGenomics to Buy, Announces $28 Price Target

Benzinga·10/06/2026 10:04:01
Listen to the news
BTIG analyst Mark Massaro upgrades NeoGenomics (NASDAQ:NEO) from Neutral to Buy and announces $28 price target.